Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
about
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins.Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific AntibodyGuiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice.
P2860
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant bispecific antibody p ...... echanism in cynomolgus monkeys
@en
Aberrant bispecific antibody p ...... chanism in cynomolgus monkeys.
@nl
type
label
Aberrant bispecific antibody p ...... echanism in cynomolgus monkeys
@en
Aberrant bispecific antibody p ...... chanism in cynomolgus monkeys.
@nl
prefLabel
Aberrant bispecific antibody p ...... echanism in cynomolgus monkeys
@en
Aberrant bispecific antibody p ...... chanism in cynomolgus monkeys.
@nl
P2093
P2860
P1476
Aberrant bispecific antibody p ...... echanism in cynomolgus monkeys
@en
P2093
Amita Datta-Mannan
Johnny E Croy
Linda Schirtzinger
Matthew Breyer
Stacy Torgerson
Victor J Wroblewski
P2860
P304
P356
10.1080/19420862.2016.1178435
P577
2016-04-25T00:00:00Z